Gene Activity List

Home Icon Home Search Icon Search Alerts Icon Stocks Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs eRecord Icon eRecord
Gene Compound Experiment Study Pathway Assay Report Bug Request Feature
Gene Activity List
You are on Page 25 of 1714:
15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35
Gene Compound Assay Inh Ic50 Ki View
5-hydroxytryptamine (serotonin) receptor 2C PERGOLIDE Serotonin 5-HT2C 94% .379uM .199uM View
histamine receptor H 2 CYPROHEPTADINE Histamine H2 94% .198uM .195uM View
tachykinin receptor 2 GW-1929 Tachykinin NK2 94% 14.509uM 4.836uM View
5-hydroxytryptamine (serotonin) receptor 2B CYPROHEPTADINE Serotonin 5-HT2B 94% .009441uM .006008uM View
solute carrier family 6 (neurotransmitter transporter, noradrenalin), member 2 PIPAMAZINE Adrenergic, Norepinephrine Transporter 94% .45uM .446uM View
Cytochrom P450-2C19 monooxygenase ECONAZOLE CYP450-2C19 Inhibition 94% .04uM NoneNone View
cytochrome P450, family 3, subfamily a, polypeptide 13 MICONAZOLE CYP450-3A4 Inhibition 94% .1uM NoneNone View
adrenergic receptor, alpha 2a MICONAZOLE Adrenergic alpha2A 94% 3.966uM 1.487uM View
A3 adenosine receptor DIETHYLSTILBESTROL Adenosine A3 94% 2.208uM 1.248uM View
sodium channel, voltage-gated, type IX, alpha DIETHYLSTILBESTROL Sodium Channel, Site 2 94% 4.735uM 4.246uM View
sodium channel, voltage gated, type VIII, alpha DIETHYLSTILBESTROL Sodium Channel, Site 2 94% 4.735uM 4.246uM View
sodium channel, voltage-gated, type VII, alpha DIETHYLSTILBESTROL Sodium Channel, Site 2 94% 4.735uM 4.246uM View
sodium channel, voltage-gated, type V, alpha (long QT syndrome 3) DIETHYLSTILBESTROL Sodium Channel, Site 2 94% 4.735uM 4.246uM View
sodium channel, voltage-gated, type IV, beta DIETHYLSTILBESTROL Sodium Channel, Site 2 94% 4.735uM 4.246uM View
sodium channel, voltage-gated, type IV, alpha DIETHYLSTILBESTROL Sodium Channel, Site 2 94% 4.735uM 4.246uM View
sodium channel, voltage-gated, type III, alpha DIETHYLSTILBESTROL Sodium Channel, Site 2 94% 4.735uM 4.246uM View
sodium channel, voltage-gated, type II, beta DIETHYLSTILBESTROL Sodium Channel, Site 2 94% 4.735uM 4.246uM View
sodium channel, voltage-gated, type II, alpha 2 DIETHYLSTILBESTROL Sodium Channel, Site 2 94% 4.735uM 4.246uM View
sodium channel, voltage-gated, type I, beta DIETHYLSTILBESTROL Sodium Channel, Site 2 94% 4.735uM 4.246uM View
sodium channel, voltage-gated, type I, alpha DIETHYLSTILBESTROL Sodium Channel, Site 2 94% 4.735uM 4.246uM View
sodium channel, voltage-gated, type IV, beta DIETHYLSTILBESTROL Sodium Channel, Site 2 94% 4.735uM 4.246uM View
sodium channel associated protein 1 DIETHYLSTILBESTROL Sodium Channel, Site 2 94% 4.735uM 4.246uM View
sodium channel, voltage-gated, type 10, alpha polypeptide 1,3-DIPHENYLGUANIDINE Sodium Channel, Site 2 94% 1.326uM 1.21uM View
sodium channel, voltage-gated, type IV, alpha polypeptide 1,3-DIPHENYLGUANIDINE Sodium Channel, Site 2 94% 1.326uM 1.21uM View
sodium channel, voltage-gated, type V, alpha polypeptide 1,3-DIPHENYLGUANIDINE Sodium Channel, Site 2 94% 1.326uM 1.21uM View
sodium channel, voltage-gated, type II, beta 1,3-DIPHENYLGUANIDINE Sodium Channel, Site 2 94% 1.326uM 1.21uM View
sodium channel, nonvoltage-gated 1 alpha 1,3-DIPHENYLGUANIDINE Sodium Channel, Site 2 94% 1.326uM 1.21uM View
sodium channel, nonvoltage-gated 1 gamma 1,3-DIPHENYLGUANIDINE Sodium Channel, Site 2 94% 1.326uM 1.21uM View
sodium channel, nonvoltage-gated 1 beta 1,3-DIPHENYLGUANIDINE Sodium Channel, Site 2 94% 1.326uM 1.21uM View
5-hydroxytryptamine (serotonin) receptor 2B FLUNARIZINE Serotonin 5-HT2B 94% 1.088uM .692uM View
gamma-aminobutyric acid A receptor, delta ZOLPIDEM GABAA, Benzodiazepine, Central 94% .069uM .056uM View
gamma-aminobutyric acid (GABA-A) receptor, subunit alpha 3 ZOLPIDEM GABAA, Benzodiazepine, Central 94% .069uM .056uM View
gamma-aminobutyric acid (GABA-A) receptor, subunit alpha 4 ZOLPIDEM GABAA, Benzodiazepine, Central 94% .069uM .056uM View
gamma-aminobutyric acid A receptor, gamma 1 ZOLPIDEM GABAA, Benzodiazepine, Central 94% .069uM .056uM View
gamma-aminobutyric acid A receptor, pi ZOLPIDEM GABAA, Benzodiazepine, Central 94% .069uM .056uM View
AT hook, DNA binding motif, containing 1 (DBSS) ZOLPIDEM GABAA, Benzodiazepine, Central 94% .069uM .056uM View
gamma-aminobutyric acid A receptor, theta ZOLPIDEM GABAA, Benzodiazepine, Central 94% .069uM .056uM View
gamma-aminobutyric acid A receptor, gamma 2 ZOLPIDEM GABAA, Benzodiazepine, Central 94% .069uM .056uM View
gamma-aminobutyric acid (GABA-A) receptor, subunit alpha 6 ZOLPIDEM GABAA, Benzodiazepine, Central 94% .069uM .056uM View
gamma-aminobutyric acid (GABA-A) receptor, subunit alpha 5 ZOLPIDEM GABAA, Benzodiazepine, Central 94% .069uM .056uM View
gamma-aminobutyric acid A receptor, alpha 2 ZOLPIDEM GABAA, Benzodiazepine, Central 94% .069uM .056uM View
gamma-aminobutyric acid A receptor, alpha 1 ZOLPIDEM GABAA, Benzodiazepine, Central 94% .069uM .056uM View
gamma-aminobutyric acid (GABA-C) receptor, subunit rho 2 ZOLPIDEM GABAA, Benzodiazepine, Central 94% .069uM .056uM View
gamma-aminobutyric acid (GABA-C) receptor, subunit rho 1 ZOLPIDEM GABAA, Benzodiazepine, Central 94% .069uM .056uM View
calcium channel, voltage-dependent, gamma subunit 8 PROPAFENONE Calcium Channel Type L, Benzothiazepine 94% .775uM .689uM View
calcium channel, voltage-dependent, gamma subunit 7 PROPAFENONE Calcium Channel Type L, Benzothiazepine 94% .775uM .689uM View
calcium channel, voltage-dependent, gamma subunit 6 PROPAFENONE Calcium Channel Type L, Benzothiazepine 94% .775uM .689uM View
calcium channel, voltage-dependent, gamma subunit 5 PROPAFENONE Calcium Channel Type L, Benzothiazepine 94% .775uM .689uM View
calcium channel, voltage-dependent, gamma subunit 4 PROPAFENONE Calcium Channel Type L, Benzothiazepine 94% .775uM .689uM View
potassium voltage-gated channel, subfamily H (eag-related), member 3 FLUNARIZINE Potassium Channel HERG 94% .6058uM .4963uM View
potassium voltage-gated channel, subfamily H (eag-related), member 4 FLUNARIZINE Potassium Channel HERG 94% .6058uM .4963uM View
potassium voltage-gated channel, subfamily H (eag-related), member 1 FLUNARIZINE Potassium Channel HERG 94% .6058uM .4963uM View
potassium voltage-gated channel, subfamily H (eag-related), member 1 FLUNARIZINE Potassium Channel HERG 94% .6058uM .4963uM View
potassium voltage-gated channel, subfamily H, member 8 TAMOXIFEN Potassium Channel HERG 94% .967uM .7922uM View
potassium voltage-gated channel, subfamily H (eag-related), member 6 TAMOXIFEN Potassium Channel HERG 94% .967uM .7922uM View
potassium voltage-gated channel, subfamily H (eag-related), member 7 TAMOXIFEN Potassium Channel HERG 94% .967uM .7922uM View
potassium voltage-gated channel, subfamily H (eag-related), member 2 TAMOXIFEN Potassium Channel HERG 94% .967uM .7922uM View
potassium voltage-gated channel, subfamily H (eag-related), member 5 TAMOXIFEN Potassium Channel HERG 94% .967uM .7922uM View
potassium voltage-gated channel, subfamily H (eag-related), member 3 TAMOXIFEN Potassium Channel HERG 94% .967uM .7922uM View
potassium voltage-gated channel, subfamily H (eag-related), member 4 TAMOXIFEN Potassium Channel HERG 94% .967uM .7922uM View
potassium voltage-gated channel, subfamily H (eag-related), member 1 TAMOXIFEN Potassium Channel HERG 94% .967uM .7922uM View
potassium voltage-gated channel, subfamily H (eag-related), member 1 TAMOXIFEN Potassium Channel HERG 94% .967uM .7922uM View
5-hydroxytryptamine receptor 6 BW-723C86 Serotonin 5-HT6 94% .6414uM .2978uM View
5-hydroxytryptamine (serotonin) receptor 2C HEXACHLOROPHENE Serotonin 5-HT2C 94% 4.6042uM 2.4117uM View
thromboxane A synthase 1 IMATINIB Thromboxane Synthetase 94% .198uM NoneNone View
thromboxane A synthase 1 (platelet, cytochrome P450, family 5, subfamily A) IMATINIB Thromboxane Synthetase 94% .198uM NoneNone View
thromboxane A synthase 1 MONTELUKAST Thromboxane Synthetase 94% 1.525uM NoneNone View
thromboxane A synthase 1 (platelet, cytochrome P450, family 5, subfamily A) MONTELUKAST Thromboxane Synthetase 94% 1.525uM NoneNone View
tachykinin receptor 2 MONTELUKAST Tachykinin NK2 94% 3.822uM 1.274uM View
sodium channel, voltage-gated, type 2, alpha 1 polypeptide 1,3-DIPHENYLGUANIDINE Sodium Channel, Site 2 94% 1.326uM 1.21uM View
sodium channel, voltage-gated, type XI, alpha 1,3-DIPHENYLGUANIDINE Sodium Channel, Site 2 94% 1.326uM 1.21uM View
sodium channel, nonvoltage-gated 1, gamma 1,3-DIPHENYLGUANIDINE Sodium Channel, Site 2 94% 1.326uM 1.21uM View
sodium channel, nonvoltage-gated 1, delta 1,3-DIPHENYLGUANIDINE Sodium Channel, Site 2 94% 1.326uM 1.21uM View
sodium channel, nonvoltage-gated 1, beta (Liddle syndrome) 1,3-DIPHENYLGUANIDINE Sodium Channel, Site 2 94% 1.326uM 1.21uM View
sodium channel, nonvoltage-gated 1 alpha 1,3-DIPHENYLGUANIDINE Sodium Channel, Site 2 94% 1.326uM 1.21uM View
sodium channel, voltage-gated, type X, alpha 1,3-DIPHENYLGUANIDINE Sodium Channel, Site 2 94% 1.326uM 1.21uM View
sodium channel, voltage-gated, type IX, alpha 1,3-DIPHENYLGUANIDINE Sodium Channel, Site 2 94% 1.326uM 1.21uM View
sodium channel, voltage gated, type VIII, alpha 1,3-DIPHENYLGUANIDINE Sodium Channel, Site 2 94% 1.326uM 1.21uM View
sodium channel, voltage-gated, type VII, alpha 1,3-DIPHENYLGUANIDINE Sodium Channel, Site 2 94% 1.326uM 1.21uM View
sodium channel, voltage-gated, type V, alpha (long QT syndrome 3) 1,3-DIPHENYLGUANIDINE Sodium Channel, Site 2 94% 1.326uM 1.21uM View
sodium channel, voltage-gated, type IV, beta 1,3-DIPHENYLGUANIDINE Sodium Channel, Site 2 94% 1.326uM 1.21uM View
sodium channel, voltage-gated, type IV, alpha 1,3-DIPHENYLGUANIDINE Sodium Channel, Site 2 94% 1.326uM 1.21uM View
sodium channel, voltage-gated, type III, alpha 1,3-DIPHENYLGUANIDINE Sodium Channel, Site 2 94% 1.326uM 1.21uM View
sodium channel, voltage-gated, type II, beta 1,3-DIPHENYLGUANIDINE Sodium Channel, Site 2 94% 1.326uM 1.21uM View
sodium channel, voltage-gated, type II, alpha 2 1,3-DIPHENYLGUANIDINE Sodium Channel, Site 2 94% 1.326uM 1.21uM View
sodium channel, voltage-gated, type I, beta 1,3-DIPHENYLGUANIDINE Sodium Channel, Site 2 94% 1.326uM 1.21uM View
sodium channel, voltage-gated, type I, alpha 1,3-DIPHENYLGUANIDINE Sodium Channel, Site 2 94% 1.326uM 1.21uM View
sodium channel, voltage-gated, type IV, beta 1,3-DIPHENYLGUANIDINE Sodium Channel, Site 2 94% 1.326uM 1.21uM View
sodium channel associated protein 1 1,3-DIPHENYLGUANIDINE Sodium Channel, Site 2 94% 1.326uM 1.21uM View
sodium channel associated protein 2 1,3-DIPHENYLGUANIDINE Sodium Channel, Site 2 94% 1.326uM 1.21uM View
sodium channel, voltage-gated, type III, beta 1,3-DIPHENYLGUANIDINE Sodium Channel, Site 2 94% 1.326uM 1.21uM View
sodium channel, voltage-gated, type I, alpha 1,3-DIPHENYLGUANIDINE Sodium Channel, Site 2 94% 1.326uM 1.21uM View
sodium channel, voltage-gated, type IX, alpha 1,3-DIPHENYLGUANIDINE Sodium Channel, Site 2 94% 1.326uM 1.21uM View
sodium channel, voltage-gated, type VII, alpha 1,3-DIPHENYLGUANIDINE Sodium Channel, Site 2 94% 1.326uM 1.21uM View
amiloride-sensitive cation channel 5, intestinal 1,3-DIPHENYLGUANIDINE Sodium Channel, Site 2 94% 1.326uM 1.21uM View
sodium channel, voltage-gated, type III, beta 1,3-DIPHENYLGUANIDINE Sodium Channel, Site 2 94% 1.326uM 1.21uM View
sodium channel, voltage-gated, type VIII, alpha polypeptide 1,3-DIPHENYLGUANIDINE Sodium Channel, Site 2 94% 1.326uM 1.21uM View
sodium channel, voltage-gated, type XI, alpha 1,3-DIPHENYLGUANIDINE Sodium Channel, Site 2 94% 1.326uM 1.21uM View
calcium channel, voltage-dependent, gamma subunit 3 PROPAFENONE Calcium Channel Type L, Benzothiazepine 94% .775uM .689uM View
calcium channel, voltage-dependent, gamma subunit 2 PROPAFENONE Calcium Channel Type L, Benzothiazepine 94% .775uM .689uM View
calcium channel, voltage-dependent, gamma subunit 1 PROPAFENONE Calcium Channel Type L, Benzothiazepine 94% .775uM .689uM View
calcium channel, voltage-dependent, beta 4 subunit PROPAFENONE Calcium Channel Type L, Benzothiazepine 94% .775uM .689uM View
calcium channel, voltage-dependent, beta 3 subunit PROPAFENONE Calcium Channel Type L, Benzothiazepine 94% .775uM .689uM View
calcium channel, voltage-dependent, beta 2 subunit PROPAFENONE Calcium Channel Type L, Benzothiazepine 94% .775uM .689uM View
calcium channel, voltage-dependent, L type, alpha 1S subunit PROPAFENONE Calcium Channel Type L, Benzothiazepine 94% .775uM .689uM View
calcium channel, voltage-dependent, alpha 1F subunit PROPAFENONE Calcium Channel Type L, Benzothiazepine 94% .775uM .689uM View
calcium channel, voltage-dependent, L type, alpha 1D subunit PROPAFENONE Calcium Channel Type L, Benzothiazepine 94% .775uM .689uM View
calcium channel, voltage-dependent, L type, alpha 1C subunit PROPAFENONE Calcium Channel Type L, Benzothiazepine 94% .775uM .689uM View
calcium channel, voltage-dependent, P/Q type, alpha 1A subunit PROPAFENONE Calcium Channel Type L, Benzothiazepine 94% .775uM .689uM View
calcium channel, voltage-dependent, beta 1 subunit PROPAFENONE Calcium Channel Type L, Benzothiazepine 94% .775uM .689uM View
calcium channel, voltage-dependent, L type, alpha 1E subunit PROPAFENONE Calcium Channel Type L, Benzothiazepine 94% .775uM .689uM View
calcium channel, voltage-dependent, N type, alpha 1B subunit PROPAFENONE Calcium Channel Type L, Benzothiazepine 94% .775uM .689uM View
calcium channel, voltage-dependent, alpha2/delta subunit 1 PROPAFENONE Calcium Channel Type L, Benzothiazepine 94% .775uM .689uM View
Cytochrom P450-2D6 monooxygenase TERBINAFINE CYP450-2D6 Inhibition 94% .2uM NoneNone View
Cytochrom P450-2D6 monooxygenase DOXAPRAM CYP450-2D6 Inhibition 94% .1uM NoneNone View
Cytochrom P450-2D6 monooxygenase PHYSOSTIGMINE CYP450-2D6 Inhibition 94% .2uM NoneNone View
Cytochrom P450-2C19 monooxygenase OXYBUTYNIN CYP450-2C19 Inhibition 94% .6uM NoneNone View
Cytochrom P450-2C19 monooxygenase PHENELZINE CYP450-2C19 Inhibition 94% .8uM NoneNone View
cholinergic receptor, muscarinic 1 DIPHENIDOL Muscarinic M1 94% .324uM .078uM View
epidermal growth factor receptor BITHIONOL Protein Tyrosine Kinase, EGF Receptor 94% .614uM NoneNone View
adrenergic receptor, alpha 2b BITHIONOL Adrenergic alpha2C 94% 4.392uM .638uM View
adrenergic receptor, alpha 2c (Non-specific probe) BITHIONOL Adrenergic alpha2C 94% 4.392uM .638uM View
opioid receptor, sigma 1 DIPHENIDOL Sigma1 94% .256uM .108uM View
adrenergic receptor, alpha 2a MAPROTILINE Adrenergic alpha2A 94% 1.824uM .684uM View
adrenergic receptor, alpha 1a FLUNARIZINE Adrenergic alpha1A 94% 1.088uM .44uM View
5-hydroxytryptamine (serotonin) receptor 2B BENZTROPINE Serotonin 5-HT2B 94% .2uM .127uM View
adrenergic receptor, alpha 2a LISURIDE Adrenergic alpha2A 94% .00031uM .000116uM View
opioid receptor, sigma 1 BUSPIRONE Sigma1 94% .504uM .212uM View
5-hydroxytryptamine (serotonin) receptor 2C LISURIDE Serotonin 5-HT2C 94% .02uM .01uM View
Protein-tyrosine kinase, Fyn ERGOTAMINE Protein Tyrosine Kinase, Fyn 94% 3.16uM NoneNone View
5-hydroxytryptamine receptor 6 PROMAZINE Serotonin 5-HT6 94% .274uM .127uM View
dopamine receptor D1A QUETIAPINE Dopamine D1 94% .4293uM .2146uM View
sodium channel, voltage-gated, type 2, alpha 1 polypeptide TERCONAZOLE Sodium Channel, Site 2 94% 2.903uM 2.602uM View
sodium channel, voltage-gated, type XI, alpha TERCONAZOLE Sodium Channel, Site 2 94% 2.903uM 2.602uM View
sodium channel, nonvoltage-gated 1, gamma TERCONAZOLE Sodium Channel, Site 2 94% 2.903uM 2.602uM View
potassium voltage-gated channel, subfamily H, member 8 CLEMASTINE Potassium Channel HERG 94% .3951uM .3237uM View
potassium voltage-gated channel, subfamily H (eag-related), member 6 CLEMASTINE Potassium Channel HERG 94% .3951uM .3237uM View
potassium voltage-gated channel, subfamily H (eag-related), member 7 CLEMASTINE Potassium Channel HERG 94% .3951uM .3237uM View
potassium voltage-gated channel, subfamily H (eag-related), member 2 CLEMASTINE Potassium Channel HERG 94% .3951uM .3237uM View
potassium voltage-gated channel, subfamily H (eag-related), member 5 CLEMASTINE Potassium Channel HERG 94% .3951uM .3237uM View
potassium voltage-gated channel, subfamily H (eag-related), member 3 CLEMASTINE Potassium Channel HERG 94% .3951uM .3237uM View
potassium voltage-gated channel, subfamily H (eag-related), member 4 CLEMASTINE Potassium Channel HERG 94% .3951uM .3237uM View
potassium voltage-gated channel, subfamily H (eag-related), member 1 CLEMASTINE Potassium Channel HERG 94% .3951uM .3237uM View
potassium voltage-gated channel, subfamily H (eag-related), member 1 CLEMASTINE Potassium Channel HERG 94% .3951uM .3237uM View
potassium voltage-gated channel, subfamily H, member 8 FLUNARIZINE Potassium Channel HERG 94% .6058uM .4963uM View
potassium voltage-gated channel, subfamily H (eag-related), member 6 FLUNARIZINE Potassium Channel HERG 94% .6058uM .4963uM View
potassium voltage-gated channel, subfamily H (eag-related), member 7 FLUNARIZINE Potassium Channel HERG 94% .6058uM .4963uM View
potassium voltage-gated channel, subfamily H (eag-related), member 2 FLUNARIZINE Potassium Channel HERG 94% .6058uM .4963uM View
potassium voltage-gated channel, subfamily H (eag-related), member 5 FLUNARIZINE Potassium Channel HERG 94% .6058uM .4963uM View
calcium channel, voltage-dependent, L type, alpha 1E subunit LOPERAMIDE Calcium Channel Type L, Benzothiazepine 94% .221uM .196uM View
calcium channel, voltage-dependent, N type, alpha 1B subunit LOPERAMIDE Calcium Channel Type L, Benzothiazepine 94% .221uM .196uM View
calcium channel, voltage-dependent, alpha2/delta subunit 1 LOPERAMIDE Calcium Channel Type L, Benzothiazepine 94% .221uM .196uM View
calcium channel, voltage-dependent, gamma subunit 8 LOPERAMIDE Calcium Channel Type L, Benzothiazepine 94% .221uM .196uM View
calcium channel, voltage-dependent, gamma subunit 7 LOPERAMIDE Calcium Channel Type L, Benzothiazepine 94% .221uM .196uM View
calcium channel, voltage-dependent, gamma subunit 6 LOPERAMIDE Calcium Channel Type L, Benzothiazepine 94% .221uM .196uM View
calcium channel, voltage-dependent, gamma subunit 5 LOPERAMIDE Calcium Channel Type L, Benzothiazepine 94% .221uM .196uM View
calcium channel, voltage-dependent, gamma subunit 4 LOPERAMIDE Calcium Channel Type L, Benzothiazepine 94% .221uM .196uM View
calcium channel, voltage-dependent, gamma subunit 3 LOPERAMIDE Calcium Channel Type L, Benzothiazepine 94% .221uM .196uM View
calcium channel, voltage-dependent, gamma subunit 2 LOPERAMIDE Calcium Channel Type L, Benzothiazepine 94% .221uM .196uM View
calcium channel, voltage-dependent, gamma subunit 1 LOPERAMIDE Calcium Channel Type L, Benzothiazepine 94% .221uM .196uM View
dopamine receptor 2 L-744832 Dopamine D2L 94% .157uM .052uM View
solute carrier family 6 (neurotransmitter transporter, serotonin), member 4 TROPISETRON Serotonin Transporter 94% .488uM .259uM View
adrenergic receptor, beta 1 PROPAFENONE Adrenergic beta1 94% .354uM .205uM View
adrenergic, beta-1-, receptor PROPAFENONE Adrenergic beta1 94% .354uM .205uM View
adrenergic receptor, alpha 2b SELEGILINE Adrenergic alpha2B 94% .376uM .172uM View
opioid receptor, sigma 1 SERTRALINE Sigma1 94% .0697uM .0293uM View
androgen receptor NORETHINDRONE ACETATE Testosterone 94% .106uM .071uM View
sodium channel, nonvoltage-gated 1, beta (Liddle syndrome) NORTRIPTYLINE Sodium Channel, Site 2 94% 1.929uM 1.759uM View
sodium channel, nonvoltage-gated 1 alpha NORTRIPTYLINE Sodium Channel, Site 2 94% 1.929uM 1.759uM View
sodium channel, voltage-gated, type X, alpha NORTRIPTYLINE Sodium Channel, Site 2 94% 1.929uM 1.759uM View
sodium channel, voltage-gated, type IX, alpha NORTRIPTYLINE Sodium Channel, Site 2 94% 1.929uM 1.759uM View
sodium channel, voltage gated, type VIII, alpha NORTRIPTYLINE Sodium Channel, Site 2 94% 1.929uM 1.759uM View
sodium channel, voltage-gated, type VII, alpha NORTRIPTYLINE Sodium Channel, Site 2 94% 1.929uM 1.759uM View
sodium channel, voltage-gated, type V, alpha (long QT syndrome 3) NORTRIPTYLINE Sodium Channel, Site 2 94% 1.929uM 1.759uM View
sodium channel, voltage-gated, type IV, beta NORTRIPTYLINE Sodium Channel, Site 2 94% 1.929uM 1.759uM View
sodium channel, voltage-gated, type IV, alpha NORTRIPTYLINE Sodium Channel, Site 2 94% 1.929uM 1.759uM View
sodium channel, voltage-gated, type III, alpha NORTRIPTYLINE Sodium Channel, Site 2 94% 1.929uM 1.759uM View
sodium channel, voltage-gated, type II, beta NORTRIPTYLINE Sodium Channel, Site 2 94% 1.929uM 1.759uM View
sodium channel, voltage-gated, type II, alpha 2 NORTRIPTYLINE Sodium Channel, Site 2 94% 1.929uM 1.759uM View
sodium channel, voltage-gated, type I, beta NORTRIPTYLINE Sodium Channel, Site 2 94% 1.929uM 1.759uM View
sodium channel, voltage-gated, type I, alpha NORTRIPTYLINE Sodium Channel, Site 2 94% 1.929uM 1.759uM View
sodium channel, voltage-gated, type IV, beta NORTRIPTYLINE Sodium Channel, Site 2 94% 1.929uM 1.759uM View
sodium channel, voltage-gated, type III, beta DICYCLOMINE Sodium Channel, Site 2 94% 1.353uM 1.234uM View
sodium channel, voltage-gated, type VIII, alpha polypeptide DICYCLOMINE Sodium Channel, Site 2 94% 1.353uM 1.234uM View
sodium channel, voltage-gated, type XI, alpha DICYCLOMINE Sodium Channel, Site 2 94% 1.353uM 1.234uM View
sodium channel, voltage-gated, type I, beta DICYCLOMINE Sodium Channel, Site 2 94% 1.353uM 1.234uM View
sodium channel, voltage-gated, type 10, alpha polypeptide DICYCLOMINE Sodium Channel, Site 2 94% 1.353uM 1.234uM View
sodium channel, voltage-gated, type IV, alpha polypeptide DICYCLOMINE Sodium Channel, Site 2 94% 1.353uM 1.234uM View
sodium channel, voltage-gated, type V, alpha polypeptide DICYCLOMINE Sodium Channel, Site 2 94% 1.353uM 1.234uM View
sodium channel, voltage-gated, type II, beta DICYCLOMINE Sodium Channel, Site 2 94% 1.353uM 1.234uM View
sodium channel, nonvoltage-gated 1 alpha DICYCLOMINE Sodium Channel, Site 2 94% 1.353uM 1.234uM View
sodium channel, nonvoltage-gated 1 gamma DICYCLOMINE Sodium Channel, Site 2 94% 1.353uM 1.234uM View
sodium channel, nonvoltage-gated 1 beta DICYCLOMINE Sodium Channel, Site 2 94% 1.353uM 1.234uM View
sodium channel, voltage-gated, type 2, alpha 1 polypeptide DICYCLOMINE Sodium Channel, Site 2 94% 1.353uM 1.234uM View
sodium channel, voltage-gated, type XI, alpha DICYCLOMINE Sodium Channel, Site 2 94% 1.353uM 1.234uM View
sodium channel, nonvoltage-gated 1, gamma DICYCLOMINE Sodium Channel, Site 2 94% 1.353uM 1.234uM View
sodium channel, nonvoltage-gated 1, delta DICYCLOMINE Sodium Channel, Site 2 94% 1.353uM 1.234uM View
sodium channel, nonvoltage-gated 1, beta (Liddle syndrome) DICYCLOMINE Sodium Channel, Site 2 94% 1.353uM 1.234uM View
sodium channel, nonvoltage-gated 1 alpha DICYCLOMINE Sodium Channel, Site 2 94% 1.353uM 1.234uM View
sodium channel, voltage-gated, type X, alpha DICYCLOMINE Sodium Channel, Site 2 94% 1.353uM 1.234uM View